Brief: Altamira Therapeutics Files Prospectus Relates To Resale Of Up To 400,000 Common Shares
16/12/2022 22:00
Dec 16 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS LTD FILES PROSPECTUS RELATES TO
RESALE,
FROM TIME TO TIME, OF UP TO 400,000 COMMON SHARES BY SELLING
SHAREHOLDER
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering